In vitro antiproliferative assays across multiple cancer cell lines, including HCT-116 and HT-29 (colorectal) and SK-OV-3 (ovarian), revealed a clear trend of diminished potency following silylation.
← all excerpts
Incorporation of Organosilicon Motifs in Natural and Synthetic Small Molecules for Anticancer Therapeutics: Current Perspectives and Future Opportunities in Drug Design.
1
—
—